INDUCTION AND PROGRESSION OF SUBCUTANEOUS NODULOSIS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB

被引：0
|
作者：
Talotta, R. [1 ]
Batticciotto, A. [1 ]
Ditto, M. C. [1 ]
Gerardi, M. C. [1 ]
Ventura, D. [1 ]
Puttin, P. Sarzi [1 ]
机构：
[1] Univ Hosp Luigi Sacco, Rheumatol Unit, Milan, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.4419
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0413
引用
收藏
页码：1194 / 1194
页数：1
相关论文
共 50 条
  • [1] Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: A case series
    Talotta R.
    Atzeni F.
    Batticciotto A.
    Ditto M.C.
    Gerardi M.C.
    Sarzi-Puttini P.
    Journal of Medical Case Reports, 12 (1)
  • [2] Weekly subcutaneous injection of tocilizumab in patients with rheumatoid arthritis
    Ito, Satoshi
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 17 - 19
  • [3] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis
    Best, Jennie H.
    Abbass, Ibrahim
    Tominna, Lenore
    Reiss, William
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 72 - 73
  • [4] Utilisation of subcutaneous Tocilizumab in rheumatoid arthritis patients in Grampian
    Philobos, M.
    Davidson, A.
    Dospinescu, P.
    SCOTTISH MEDICAL JOURNAL, 2019, 64 (03) : NP39 - NP39
  • [5] Subcutaneous tocilizumab for the treatment of rheumatoid arthritis
    Mitchell, Emma
    Jones, Graeme
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (02) : 103 - 114
  • [6] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis Response
    Punekar, Rajeshwari
    Choi, Jeannie
    Boklage, Susan H.
    Iglesias-Rodriguez, Melitza
    Nola, Kamala
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 73 - 73
  • [7] Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab
    Rubbert-Roth, Andrea
    Sebba, Anthony
    Brockwell, Laura
    Kelman, Ariella
    Porter-Brown, Benjamin
    Pulley, Jennifer
    Napalkov, Pavel
    van Vollenhoven, Ronald F.
    RMD OPEN, 2016, 2 (01):
  • [8] INCIDENCE OF MELANOMA IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMAB
    Gale, S.
    Wang, J.
    Nebesky, J. M.
    Linke, A. T.
    Berber, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 579 - 579
  • [9] PREGNANCY OUTCOMES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Ishikawa, H.
    Kaneko, A.
    Hattori, Y.
    Takahashi, N.
    Kida, D.
    Sato, T.
    Osawa, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 501 - 502
  • [10] Risk of infections in rheumatoid arthritis patients treated with tocilizumab
    Lang, Veronika R.
    Englbrecht, Matthias
    Rech, Juergen
    Nuesslein, Hubert
    Manger, Karin
    Schuch, Florian
    Tony, Hans-Peter
    Fleck, Martin
    Manger, Bernhard
    Schett, Georg
    Zwerina, Jochen
    RHEUMATOLOGY, 2012, 51 (05) : 852 - 857
12345